Merrimack Pharmaceuticals (NASDAQ:MACK – Get Free Report) and Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Merrimack […]
Merrimack Pharmaceuticals (NASDAQ:MACK) Rating Lowered to Sell at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com lowered shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Free Report) from a hold rating to a sell rating in a report issued on Tuesday. Merrimack Pharmaceuticals Stock Down 0.4 % MACK stock opened at $13.25 on Tuesday. The business has a fifty day moving average of $13.10 and a two-hundred day moving average of $12.52. […]
Financial Analysis: Cellectar Biosciences (NASDAQ:CLRB) vs Merrimack Pharmaceuticals (NASDAQ:MACK) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Financial Analysis: Cellectar Biosciences (NASDAQ:CLRB) vs Merrimack Pharmaceuticals (NASDAQ:MACK) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.